International Reference Pricing in Medicare—A Mismatch Between Policy and Evaluation
Year: 2026
Type: article
Abstract: This Viewpoint explores whether savings from lower drug prices outweigh any downstream effects on manufacturer behavior, patient access, and future pharmaceutical innovation.
Source: JAMA Health Forum
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $5,000
OpenAlex ID: W7226003501
